Table 5.
Variables | Overall Survival |
||
---|---|---|---|
HR | 95% CI | p Value | |
miR-155 (low versus high) | 1.681 | 0.3333–8.280 | 0.540 |
miR-27b (low versus high) | 1.215 | 0.2458–6.126 | 0.807 |
miR-29a (low versus high) | 2.484 | 0.5871–15.15 | 0.197 |
Age (≤47 versus >47 years) | 1.749 | 0.3501–8.657 | 0.506 |
Tumor grade (I-II versus III) | 0.560 | 0.07296–3.501 | 0.493 |
Nuclear grade (low versus high and intermediate-high) | 1.977 | 0.1596–40.67 | 0.517 |
Tumor stage (T1-T2 versus T3-T4) | 0.5445 | 0.1041–2.891 | 0.800 |
Tumor size (<2 versus ≥2 cm) | 0.460 | 0.04656–2.841 | 0.347 |
Area of invasive component (<4 versus ≥4 cm2) | 0.576 | 0.07625–3.827 | 0.378 |
Tumor side (right versus left) | 0.585 | 0.1185–2.937 | 0.525 |
Margin (free versus involved) | 0.507 | 0.05886–3.166 | 0.416 |
Prevascular invasion (negative versus positive) | 1.605 | 0.3264–8.170 | 0.566 |
Preneural invasion (negative versus positive) | 0.336 | 0.01890–1.809 | 0.166 |
CI, confidence interval; HR, hazard ratio.